feed,title,long_url,short_url
Investors,AstraZeneca Dips On Surprise Miss For Gilead-Rivaling Cancer Drug,https://www.investors.com/news/technology/astrazeneca-stock-daiichi-sankyo-adc-breast-cancer/,https://da.gd/EhpY
Investors,Biohaven Surges After Delaying Progression By Up To 70% In A Rare Disease,https://www.investors.com/news/technology/biohaven-stock-sca-treatment/,https://da.gd/2l2dDP
